Monday, January 30, 2023
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
Daily Remedy
  • Home
  • Articles
  • Podcasts
    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    November 25, 2022
    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    November 25, 2022
    A conversation with Dr. Edwin Leap, physician writer and emergency medicine physician

    A conversation with Dr. Edwin Leap, writer and emergency medicine physician

    November 8, 2022
    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    October 31, 2022
    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    October 23, 2022
    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    October 23, 2022
  • Surveys

    Surveys

    Does inflation affect how you use your deductible?

    Does inflation affect how you use your deductible?

    by Jay K Joshi
    December 12, 2022

    Survey Resutls

    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    October 16, 2022
  • About Us
  • Contact us
  • Support Us
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    November 25, 2022
    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    November 25, 2022
    A conversation with Dr. Edwin Leap, physician writer and emergency medicine physician

    A conversation with Dr. Edwin Leap, writer and emergency medicine physician

    November 8, 2022
    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    October 31, 2022
    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    October 23, 2022
    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    October 23, 2022
  • Surveys

    Surveys

    Does inflation affect how you use your deductible?

    Does inflation affect how you use your deductible?

    by Jay K Joshi
    December 12, 2022

    Survey Resutls

    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    October 16, 2022
  • About Us
  • Contact us
  • Support Us
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Politics & Law

COVID Innovations, Solutions to Keep a Market Going

Jay K Joshi by Jay K Joshi
April 23, 2022
in Politics & Law
0
COVID Innovations, Solutions to Keep a Market Going

When a market changes, the market incumbents are the last to know. Not because they cannot see the signs, but because they prefer to remain blind.

It is why Blockbuster fell to Netflix, and why cable news networks are now losing ground to streaming services. The signs of a changing market are obvious, even while nascent, but market leaders often ignore them. After all, why innovate when you can simply replicate the existing revenue model and continue to cash in?

This sentiment applies to many market leading companies who shot to cash flow stardom during the pandemic. It is no secret that Pfizer celebrated its most profitable year to date after a year of selling billions of COVID-19 vaccines across the world. Why let the waning pandemic stop the gravy train? Just a month earlier, Pfizer along with Moderna applied for emergency use authorization for a fourth dose, despite the data proving to be more equivocal than ever. Profits are to be earned, clinical data be damned.

While Pfizer and Moderna may be the most egregious players in the never ending COVID market, they are far from the only ones. Dozens of market incumbents and well-funded upstarts are competing to profit from the COVID innovation market. All they need is for the market to continue thriving.

Just recently, the FDA approved the first aerosolized test for COVID-19. The InspectIR COVID-19 Breathalyzer — which is about the size of a carry-on bag — can identify five volatile organic compounds tied to COVID-19 in a person’s breath using a technique known as gas chromatography, delivering results within minutes. Apparently, we still need rapid tests. Who knew?

In keeping with the theme of offering airborne treatments for airborne viruses, a research collaborative between Northwestern University and Washington University, St. Louis developed an aerosolized treatment for those presenting with symptomatic complications from COVID-19. Designed through computational algorithms and tested in preclinical labs, this compound blocks COVID-19 from entering vulnerable cells in the human body.

It is a marvelous feat of research and engineering – only it is two years too late – assuming we are going by conventional measures of the pandemic timeline. But if we adjust the timeline to keep the COVID market flourishing, then we are perfectly timed.

Just ask the pharmaceutical companies that continue to dole out COVID-19 pills. There are four generally accepted oral medications for COVID. Of the four, Paxlovid is the most accessible and widely available – see the most profitable. And its manufacturers are keen to tout as much.

What does all of this innovation really amount to? The pandemic is waning, well on its way to the annals of history, both in the minds of the public and in the publicly available health data. People have moved on, but the COVID innovation market continues to churn out new forms of therapy. How does that make any sense?

Well, it makes sense when you view the matter from the perspective of industry regulations. The Centers for Medicare and Medicaid Services, CMS, continues to maintain the same reimbursement codes that were modified during the pandemic. So, from a reimbursement standpoint, the pandemic is alive and kicking. And in a heavily regulated market, the regulations define the market. If we are continuing to use COVID reimbursement codes, then for all intents and purposes, the pandemic is still lingering.

For COVID innovations to remain profitable, the market must remain strong. And for the COVID market to remain strong, the pandemic must continue to surge. Even if it means propping industry regulations for a disease that affects fewer and fewer people by the day. This makes for a curious conundrum. How can we trust the powers-that-be to be honest when they stand to profit so mightily from an ongoing pandemic?

Pharmaceutical companies profit from more drug sales. Startups profit from strong market growth. And regulators benefit from overseeing all of it. There is little incentive, from a structural standpoint, to move on from the pandemic – even if the public has all but done so.

It highlights how innovation markets do not reflect those who benefit from such innovations – and reveals yet another disconnect between the patient and the healthcare market.

ShareTweet
Jay K Joshi

Jay K Joshi

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

YouTube Video VVUxUDVQenU5RTFjUVFKNDY2ZlBmdFB3LmdVUm55WVpqRmNn This is a video about Elemental/Essential Frameworks of Healthcare Law

00:00 Elemental/Essential Frameworks of Healthcare Law
Load More... Subscribe

Expert vs. Lay Testimony

Visuals

NADAC (National Average Drug Acquisition Cost)

NADAC (National Average Drug Acquisition Cost)

by Jay K Joshi
January 29, 2023
0

We list the acquisition price of drugs that are covered under the Medicaid Drug Rebate Program - effectively, how much does the government pay for common drugs utilized by patients on Medicaid. Drugs listed are from A-CH.  

Read more

Twitter Updates

Tweets by DailyRemedy1

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

Popular

  • Letter to the Alabama Board of Medical Examiners

    Letter to the Alabama Board of Medical Examiners

    0 shares
    Share 0 Tweet 0
  • Prosecuting Doctors as Drug Dealers

    0 shares
    Share 0 Tweet 0
  • Why Our Prescribing were for Patients’ Best Interests

    0 shares
    Share 0 Tweet 0
  • Malicious Prosecution and Fabrication of Evidence

    0 shares
    Share 0 Tweet 0
  • My Respect for the Law

    0 shares
    Share 0 Tweet 0

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2023 Daily Remedy

No Result
View All Result
  • Home
  • Articles
    • Contrarian
    • Financial Markets
    • Innovations & Investing
    • Perspectives
    • Politics & Law
    • Trends
    • Uncertainty & Complexity
  • Podcasts
  • Surveys
    • Survey Results
  • About Us
  • Contact us
  • Support Us

© 2023 Daily Remedy

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do